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Model-Based Therapy 
Planning Allows Prediction of 
Haemodynamic Outcome after 
Aortic Valve Replacement
M. Kelm1,7, L. Goubergrits1,2,7, J. Bruening2, P. Yevtushenko2, J. F. Fernandes1, S. H. 
Sündermann4, F. Berger1,3,5, Falk4,5,6, T. Kuehne1,3,7, CARDIOPROOF group* & S. Nordmeyer1,7
Optimizing treatment planning is essential for advances in patient care and outcomes. Precisely tailored 
therapy for each patient remains a yearned-for goal. Cardiovascular modelling has the potential to 
simulate and predict the functional response before the actual intervention is performed. The objective 
of this study was to proof the validity of model-based prediction of haemodynamic outcome after aortic 
valve replacement. In a prospective study design virtual (model-based) treatment of the valve and the 
surrounding vasculature were performed alongside the actual surgical procedure (control group). The 
resulting predictions of anatomic and haemodynamic outcome based on information from magnetic 
resonance imaging before the procedure were compared to post-operative imaging assessment of 
the surgical control group in ten patients. Predicted vs. post-operative peak velocities across the 
valve were comparable (2.97 ± 1.12 vs. 2.68 ± 0.67 m/s; p = 0.362). In wall shear stress (17.3 ± 12.3 Pa 
vs. 16.7 ± 16.84 Pa; p = 0.803) and secondary flow degree (0.44 ± 0.32 vs. 0.49 ± 0.23; p = 0.277) 
significant linear correlations (p < 0.001) were found between predicted and post-operative outcomes. 
Between groups blood flow patterns showed good agreement (helicity p = 0.852, vorticity p = 0.185, 
eccentricity p = 0.333). Model-based therapy planning is able to accurately predict post-operative 
haemodynamics after aortic valve replacement. These validated virtual treatment procedures open up 
promising opportunities for individually targeted interventions.
Precisely tailored treatment remains an essential goal across several areas of medicine1–3. The ability to model, and 
thus to predict the functional response before the actual surgical procedure is performed holds great promise for 
improvements in heart valve surgery and has remained a yearned-for goal4–7.
Aortic valve disease (AVD) is the most common type of heart valve disease, with a broad set of treatment 
options and a steadily growing number of patients undergoing aortic valve replacement (AVR) and recurrent 
interventions4, 8. Clinical guidelines provide the current standards for medical decision making such as indica-
tions for surgical valve interventions. They also highlight the need for reliable treatment procedures and heart 
valve types that re-establish physiologic haemodynamics9, 10. Conversely, even after treatment most patients show 
abnormal blood flow patterns5. This is important because alterations in secondary flow and wall shear stress 
(WSS)11, 12 can trigger endothelial cell dysfunction and wall remodelling of the aorta13, 14. Abnormal flow patterns 
were shown to contribute to longer-term mortality and morbidity, including aortic aneurysm formation15–17, left 
ventricular remodelling and recurrent interventions4, 18, 19.
Valid prediction of post-operative haemodynamic outcome would be essential to identify the optimal type of 
treatment in a given anatomy. Computational fluid dynamics (CFD) has been used to gain additional information 
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about haemodynamic parameters that are not directly assessable by clinical imaging technologies alone20. 
Imaging-based CFD was shown to provide valid functional information in a variety of cardiovascular diseases, 
offering additional guidance in the process of pre-treatment planning21–23.
However, a fully operational virtual valve treatment procedure requires the combination of several key ele-
ments and has therefore remained challenging and lacks clinical validation: (1) the patient-specific cardiovascular 
anatomy and (2) patient-specific flow characteristics need to be properly represented digitally; (3) virtual valve 
replacement procedure has to be performed in conjunction with (4) appropriate virtual modifications to the 
ascending aorta. Based on these patient-specific boundary conditions (5) CFD simulations are required and, 
finally (6), such individual model-based predictions need to be validated against the post-operative outcome after 
surgical AVR. In this study we aimed to combine these steps and validate the model-based prediction of haemo-
dynamic outcome after AVR.
Materials and Methods
Study design and conduct. A virtual intervention study was performed in parallel to the actual surgical 
treatment (control group) using a single-case design in patients with AVD (Fig. 1). Ten patients with an indication 
for AVR with or without treatment of the ascending aorta were prospectively enrolled into the study meeting 
the inclusion criteria of the AVD study arm of the CARDIOPROOF trial. Patient characteristics are shown in 
Table 1. Table 2 summarises treatment information according to patient diagnosis. AVR typically includes open-
heart surgery to replace the damaged native aortic valve with an artificial valve. The David procedure describes a 
method of aortic root replacement while sparing the aortic valve. During Ross procedure the diseased aortic valve 
is replaced with the patient’s own pulmonary valve.
All patients received a pre-operative magnetic resonance imaging (MRI) examination. At a median of 
56 (5–277) days (see Table 2) after the operation all patients underwent a follow-up assessment, including 
post-treatment MRI. Using individual pre-treatment MRI data virtual valve replacement and model-based pre-
diction of post-treatment haemodynamic outcome were performed in all patients, followed by a validation anal-
ysis comparing predicted and post-operative outcome.
The primary validation endpoints of the study were peak velocities across the valve and blood flow patterns 
across the valve (helicity, vorticity, and eccentricity). Secondary endpoints were wall shear stress and secondary 
flow degree.
The study was carried out according to the principles of the Declaration of Helsinki and approved by the 
local ethics committee (Ethics committee - Charité - Universitätsmedizin Berlin). Written informed consent was 
obtained from the participants and/or their legal guardians.
MRI assessment. Cardiac MRI examinations were performed using a 1.5 Tesla Achieva R5.1.8. MRI scan-
ner with a five-element cardiac phased-array coil (Philips Medical Systems, Best, The Netherlands). MRI pro-
tocols included routine three-dimensional anatomical imaging in end-diastole. The sequence parameters used 
were: acquired voxel 0.66 × 0.66 × 3.2 mm, reconstructed voxel 0.66 × 0.66 × 1.6 mm, repetition time 40 ms, 
echo time 2.0 ms, flip angle 90°, number of signal averages 3. Four-dimensional velocity-encoded MRI (4D VEC 
Figure 1. Design of the virtual intervention study. In parallel to the surgical treatment (Group A, control 
group) a virtual intervention was performed in a digital representation of the patients (Group B). Individual 
models were built in all patients. The predicted outcome after a virtual procedure was reassessed by 
computational fluid dynamics (CFD) and compared to the surgical control.
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MRI) was used to capture flow data of the left ventricular outflow tract and the thoracic aorta (acquired voxel 
2.5 × 2.5 × 2.5 mm, reconstructed voxel 1.7 × 1.7 × 2.5 mm, repetition time 3.5 msec, echo time 2.2 msec, flip 
angle 5°, 25 reconstructed cardiac phases, number of signal averages (1). Scan time varied between 9 and 14 min-
utes, depending on the size of the patient’s chest. High velocity encoding (3–6 m/s) in all three directions was used 
in order to avoid phase wraps in the presence of the valve stenosis or secondary flow. All flow measurements were 
completed with automatic correction of concomitant phase errors.
Post-processing. Pre- and post-treatment anatomical MRI image data (3D MRI) of the aortic arch includ-
ing the left ventricular outflow tract (LVOT) were segmented and reconstructed using ZIBAmira 2013.55 (Zuse 
Institute Berlin, Berlin, Germany) according to previous descriptions12. For qualitative visualisation and quanti-
tative measurements of blood flow patterns within the ascending aorta 4D VEC MRI data analysis was performed 
using Gyrotools Flow (Release 2.2.15, Gyrotools, Zurich, Switzerland). Scalar maps (through-plane flow analysis) 
for grading of eccentricity were performed at three levels along the ascending aorta. Measurement at level 1 was 
performed just above the aortic valve, at level 2 caudally and at level 3 cranially to the pulmonary artery bifur-
cation. Aliasing was excluded in every image plane used for blood flow quantification in 4D VEC MRI. In order 
to use the personalised three-dimensional LVOT inflow velocity profile as inlet boundary condition for flow 
modelling, data were extracted from 4D VEC MRI using MEVISFlow (version 10, Fraunhofer MEVIS, Bremen, 
Germany) and interpolation on to computational mesh used ZIBAmira.
Virtual treatment. The reconstruction of the pre-treatment anatomy was used for the virtual valve replace-
ment procedure. The valve region corresponding to the height of the valve prosthesis ring including a margin 
Characteristics Patients (n = 10)
Age, median (range), years 51 (13–71)
Sex, no., m/f 9/1
Weight, median (range), kg 67 (55–98)
Height, median (range), cm 172 (162–185)
Body surface area, median (range), m² 1.8 (1.6–2.2)
Mean pressure across aortic valve, median (range), mmHg 36 (4–88)
Bicuspid aortic valve morphology, no. (%) 8 (80)
Aortic valve insufficiency, no. (%) 4 (40)
Aortic valve stenosis, no. (%) 6 (60)
Combined Aortic Valve lesion, no. (%) 2 (20)
Dilation of the ascending aorta, no. (%) 5 (50)
Ascending aorta Diameter, median (range), Z-score 3 (−3–9)
MRT-LVEF, median (range), % 63 (46–82)
MRT-LVEDV, median (range), ml/m² 79 (50–195)
Baseline systolic blood pressure, median (range), mmHg 138 (114–174)
Baseline diastolic blood pressure, median (range), mmHg 78.5 (45–100)
Baseline heart rate, median (range), bpm 71.5 (49–91)
Table 1. Baseline characteristics. LVEF = left ventricular ejection fraction, LVEDV = left ventricular end-
diastolic volumes.
Patient Diagnoses Valve treatment
Valve 
diameter




1 AI,AS,BAV On-X Aortic(m) 23 mm — 49
2 BAV,DA David I procedure(b) — Hemashield, 30 mm 7
3 AI,BAV Ross procedure(b) — — 174
4 AI,BAV,DA SJM Masters HP(m) 25 mm Hemashield, 32 mm 10
5 AS CE Magna Ease(b) 21 mm — 63
6 AS,BAV CE Perimount(b) 25 mm — 277
7 AS,BAV,DA Medtronic HancockII(b) 21 mm Reduction aortoplasty 137
8 AS,AI,BAV Medtronic AVG(m) 21 mm Hemashield, 24 mm 5
9 AS*,DA SJM Regent repair(m) 23 mm Hemashield, 28 mm 121
10 AS,BAV Medtronic AP360(m) 20 mm — 102
Table 2. Surgical treatment data. DA – dilated ascending aorta; BAV – bicuspid aortic valve; AI – aortic valve 
insufficiency; AS – aortic valve stenosis; (m) – mechanical valve; (b) – biological valve; SJM – St Jude Medical; 
CE – Carpentier Edwards, *stenosis of the mechanical valve.
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of 3 mm in both directions was subsequently cut out using ZIBAmira. Computer models of valve prostheses 
(mechanical or biological valve) were inserted into the valve area using Gambit 2.4.6 (Ansys, Inc., Canonsburg, 
PA, USA) and the resulting surface was smoothed and cleaned using ReMESH version 2.0 (IMATI, Genoa, Italy) 
and MeshLab version 1.3.3 (ISTI, Pisa, Italy), respectively.
The type and size of mechanical valve was modelled according to the valve used during actual surgical treat-
ment (Table 2). Patient 9 was a special case with stenosis of the mechanical valve prosthesis by a thrombus, 
which prevented one of two leaflets to function adequately. During surgical procedure the thrombus was removed 
and the valve function (opening and closing) was re-established without further need for valve replacement. 
Consequently, we called this case valve “repair”. In case of the insertion of biological valves, models were gen-
erated using the Fisics-Incor valve (INCOR, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil). 
This valve approximates the anatomy of a set of commonly used biological valve prostheses, e.g. Hancock II and 
Mosaic valves (both Medtronic, Dublin, Ireland), Trifecta valve (St. Jude Medical, Inc., Saint Paul, MN; USA) and 
Perimount valve series (Edwards Lifesciences, Irvine, CA, USA). All virtual valve geometries were available in the 
STL file format as valve surfaces with leaflets in the fully open position and are part of a digital valve data base. 
The biological valves were based on 3D optical scanning as described before24 and were scaled to fit the size of the 
valve prosthesis used, while the mechanical valve models were generated using computer aided design software 
(CAD) (SolidWorks Corp., Waltham, MA, USA). In cases of surgical treatment of the ascending aorta (e.g. by 
Hemashield prostheses, Boston Scientific, MA, USA), aortic geometry of CFD models was modified accordingly 
during the virtual treatment procedure. In case of David and Ross procedure we hypothesized an ideal aortic 
valve generated according to a mathematical procedure proposed by Labrosse et al.25. In one case the aortic root 
was virtually replaced by a virtual graft of constant diameter, according to a digital representation of a type I 
David procedure.
Computational fluid dynamics (model-based predictions). Computational fluid dynamics (CFD) uses 
a numerical approach to assess flows (pressure and velocity fields). Necessary boundary conditions for CFD include 
anatomical data as well as inflow and outflow conditions. These data were based on individual MRI imaging data 
from each patient. Besides the predictive simulation after virtual treatment CFD with consistent inlet and outlet 
boundary conditions was used to assess additional haemodynamic parameters of the post-operative aortic anatomy.
Pre-treatment 4D VEC MRI data were used to set peak systolic flow conditions in the LVOT/ascending aorta 
and in the descending aorta. Flow rates in the head-neck vessels were calculated based on Murray’s law for the 
relation between flow rate and vessel diameter Q ~ d3 for branching vessels. Flow was simulated using ANSYS 
Fluent 14.5 (ANSYS Inc., Canonsburg, PA, USA) solving Navier-Stokes equations for the mass and momen-
tum conservation laws. A non-Newtonian blood model was applied using an adapted power law model26. A k-ω 
SST transition turbulence model assuming constant turbulence intensity of 5% at the inlet surface was used. 
At the inlet of the simulated anatomy (LVOT) the velocity profile (three velocity components) was taken from 
pre-treatment 4D VEC MRI data and set for each node of the inlet boundary surface mesh using user defined 
function (programmed routine written in C). The procedure was described previously in the literature23. At all 
outlets the outlet boundary condition defining the flow rate at each outlet surface mesh applying zero diffusion 
flux for all flow variables and an overall mass balance correction was used. High-quality unstructured volume 
meshes accounting for approximately 5 million cells varying with the volume of the aorta were fabricated with 
the Gambit (ANSYS Inc.) following requirements and a mesh independence study for flow analysis in the aorta 
and aortic valve23, 24. Convergence criteria were set to residual errors <10−5. The methodology of the virtual AVR 
validation study is summarized in Fig. 2.
Comparison of anatomy between virtual and post-operative treatment. Anatomical differences 
were analysed by comparing averaged diameters of the ascending aorta as well as surface distances for aortic 
region without valve region. After alignment of the region of interest (common regions in both geometries) sur-
face distances were calculated and quantified as mean surface distance with standard deviation and the Hausdorff 
distance (a measure of the maximal surface distance).
Comparison between predicted and post-operative haemodynamic outcome. Predicted 
post-treatment blood flow patterns and velocities across the aortic valve were validated against the hemodynamic 
outcome after the actual surgical procedure. Based on CFD peak velocities were calculated and streamlines were 
visualised. These blood flow patterns were compared to measured 4D VEC MRI flow fields after surgical treat-
ment. As described in recent clinical literature5, 6, 13 the comparison of helicity, vorticity and eccentricity of flow in 
the ascending aorta between post-operative 4D VEC MRI and CFD simulations was performed. Flow patterns in 
the ascending aorta were visualized using streamlines. Helical flow describes flow circulating along the longitudi-
nal axis of the ascending aorta and vortical flow describes flow circulating along the vertical axis of the ascending 
aorta. Categorical grading was performed for describing the degree of helical and vortical flow profiles as follows: 
none = normal flow profiles, mild = flow rotation <360°, marked = flow rotation >360°. Eccentric flow was vis-
ualized using through plane velocity information in the ascending aorta. Grading was performed as follows: 
none = high velocity systolic flow was located in the centre of the vessel lumen, mild eccentric = high velocity 
systolic flow was not located centrally and was present in one- to two-thirds of the vessel lumen, marked eccen-
tric = high velocity systolic flow is present along the rim of the vessel wall only (<one-third of the vessel lumen).
Secondary flow degree (SFD) is defined as the relationship between plane-averaged in-plane velocities to the 
through-plane velocity magnitudes23 and can be obtained from CFD simulations. In an additional validation step 
SFD was calculated based on predicted CFD, and compared to a CFD simulation based on MRI measurements 
after surgical treatment. The same was done to assess wall shear stress (WSS). In addition to surface-averaged 
WSS (WSSSA) we also analysed WSS based on the Hagen-Poiseuille law (WSSHP). WSSHP is defined as WSS in a 
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pipe with laminar full-developed flow (parabolic velocity profile): WSSHP = ƞ × 4 × Vmean/Rmean, where ƞ is the 
dynamic viscosity of the blood (3.5 × 10−3 Pa·s), Vmean is the mean forward (through-plane) velocity and Rmean 
is the mean radius of the ascending aorta. At the same volume flow rate WSSSA increases as secondary flow (e.g. 
vorticity, helicity) increases, whereas, WSSHP remains constant. The simplified WSSHP parameter simultaneously 
illustrates the impact of errors in post-treatment aortic diameter prediction, which exists even in the absence of 
complex flow patterns, as well as the difference between real and idealized WSS caused by secondary flow pat-
terns. WSSSA and WSSHP after virtual treatment were compared to post-surgical values. The validation process is 
illustrated in Fig. 2.
Statistical analysis. Data are presented as means ± standard deviation, unless stated otherwise. All data 
was tested for normality using a Kolmogorov-Smirnov test. Normally distributed data were analysed using paired 
t-test to compare differences between the predicted and post-operative haemodynamic parameters. Correlations 
were assessed by linear regression analysis. Friedman test was used to evaluate differences in blood flow patterns 
(eccentricity, helicity, vorticity) between methods. SPSS version 21 (IBM Corp., Armonk, NY, USA) was used for 
statistical analysis. In this study, Bonferroni correction was used to adjust for multiple validation endpoints and 
differences were considered significant if p < 0.0083. Bland-Altman plots were plotted to describe differences of 
measures between post-operative and predicted outcome.
Results
Anatomy. The analysis of anatomical differences between virtual and post-operative geometry found no 
significant differences between averaged diameters of the ascending aorta (28.3 ± 5.7 mm vs. 29.6 ± 6.9 mm, 
Figure 2. Virtual aortic valve replacement and clinical validation. The virtual aortic valve replacement procedure 
is outlined (upper panel of the figure). After virtual treatment a patient-specific computational fluid dynamic 
(CFD) simulation is performed, resulting in a prediction of the haemodynamic outcome. In the clinical validation 
process (lower panel of the figure) this outcome is compared against the clinical outcome of the patient.
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t = 1.684, d.f. (degrees of freedom) = 9, p = 0.126). A significant (p < 0.001) linear correlation Dvirt = 1.0484 × Dreal 
with R2 = 0.893 was found.
The averaged surface distance between two reconstructed ascending aorta surfaces for 10 cases was 
1.9 ± 1.48 mm and therefore of the same order as the voxel resolution of MRI sequences used for the segmenta-
tion procedure. The averaged Hausdorff distance was 6.99 ± 4.21 mm (Fig. 3).
Haemodynamic outcome. Predicted and post-operative blood flow profiles in the ascending aorta were 
comparable in all patients (Fig. 4). Categorical grading of helicity, vorticity and eccentricity of blood flow in the 
ascending aorta between post-operative and predicted outcome did not show significant differences (helicity 
p = 0.852, vorticity p = 0.185, eccentricity p = 0.333) (Fig. 5A). Maximal velocity across the aortic valve was not 
significantly different (2.97 ± 1.12 vs. 2.68 ± 0.67 m/s; t = 0.96, d.f. = 9, p = 0.362) and a significant (p < 0.001) 
linear correlation with R2 = 0.907 and a coefficient of 1.097 was found between predicted and post-operative 
maximal velocity magnitudes. Differences between predicted and the post-operative maximum velocities are 
visualized by Bland-Altman plots (Fig. 5D). CFD predicted transvalvular pressure drops across the virtual 
inserted valve prosthesis for the individual patients was as follows: (1–6.6 mmHg, 2–1.2 mmHg, 3–9.1 mmHg, 
4–0.8 mmHg, 5–1.4 mmHg, 6–1.3 mmHg, 7–6.2 mmHg, 8–33.8 mmHg, 9–2.8 mmHg, 10–11.2 mmHg).
Comparison of secondary flow degree (SFD) in the ascending aorta between predicted and post-operative 
outcome found no significant differences (0.44 ± 0.32 vs. 0.49 ± 0.23; t = 1.156, d.f. = 9, p = 0.277) whereas signif-
icant (p < 0.001) linear correlation with R2 = 0.802 and a coefficient of 0.965 was found. The differences between 
predicted and post-operative SFD are visualised by Bland-Altman plots (Fig. 5B).
Hagen-Poiseuille based estimation of WSS in the ascending aorta in the predicted and post-operative treat-
ment group showed comparable results (0.92 ± 0.91 Pa vs. 0.98 ± 0.96 Pa; t = 1.248, d.f. = 9, p = 0.243) with a 
significant linear correlation (WSSHP,virt = 0.94 × WSSHP,real) (p < 0.001, R2 = 0.977). Similar results were found 
for WSSSA values: no significant differences (17.3 ± 12.3 Pa vs. 16.7 ± 16.84 Pa; t = 0.259, d.f. = 9, p = 0.802), and 
a significant (p < 0.001) linear correlation with R2 = 0.821 and a coefficient of 1.06. The differences between pre-
dicted and the post-operative WSS are visualised by Bland-Altman plots (Fig. 5C). Individual WSS distributions 
are shown in Fig. 6.
Discussion
The valid prediction of haemodynamics after aortic valve and vascular surgery opens up several opportunities for 
individualized pre-treatment planning, decision making and optimisation in patients with AVD. We were able 
to successfully perform the virtual procedure in ten patients with varying types of AVD and to use model-based 
therapy planning for accurate prediction of post-operative haemodynamic outcome after AVR. Thus, a fully oper-
ational virtual valve treatment procedure with all its challenges described was shown to be applicable in a first 
disease-specific study cohort of AVD patients.
Based on a fully non-invasive MRI assessment, treatment can be simulated prior to the actual procedure and 
entirely free of risk to the patient. Pursuing the aim of physiological flow condition restoration after AVR, the 
prediction of flow profiles can be helpful for decision making concerning (1) valve type, (2) size, (3) position, and 
(4) modifications to the ascending aorta. The avoidance of alterations in secondary flow and WSS can already help 
to limit several risk factors associated with long-term morbidity and mortality after AVR16–18. Furthermore, recent 
publications focusing on post-operative haemodynamic outcome after aortic valve surgery have shown significant 
differences between different types of valve prostheses5, 6, 27. In our patient population a high standard deviation 
for all examined parameters was observed, reflecting such high inter-individual variability after surgical treat-
ment, as well as in its virtually predicted counterpart. While high variance is a strong motivator for improving 
Figure 3. The comparison of aortic geometries (example). The accuracy of the vascular geometry is verified in 
order to ensure accurately set boundary conditions (A) The virtual anatomy is automatically overlaid with the 
actually resulting anatomy, providing mean differences between both measures and the Hausdorff distance. (B) 
shows the surfaces distance between geometries.
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treatment planning in the future it was accepted in the validation study as it replicates current clinical practice. 
There is still a marked eccentric flow pattern seen post-operatively in the majority of patients, which has been pre-
dicted correctly. The degree of eccentricity has been shown to be associated with the degree of growth rate of the 
ascending aorta in patients with bicuspid aortic valves28. Regarding WSS it has been described, that elevated local-
ized WSS was associated with typical patterns of ascending aorta dilation29. In our patient population we have 
found regions of increased WSS leading to a higher value of averaged WSS along the ascending aorta. However, 
in order to possibly predict a none-eccentric flow pattern or a normalized WSS pattern along the ascending aorta, 
the validated procedure needs to be applied to patient specific geometries in combination with different types of 
devices or different surgical techniques30. The opportunity to test a diverse set of surgically implantable devices in 
Figure 4. Visualization of flow patterns using CFD simulations based on post-operative imaging data (post-
operative) and virtually treated preoperative imaging data (predicted).
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a given patient-specific anatomy carries the potential for additional decision support regarding procedure types 
– potentially reducing the risk for recurrent interventions31, 32.
In the majority of patients Bland-Altman plots showed sufficient agreement and regression plots showed good 
correlations for maximal velocity across the aortic valve, SFD and WSS in the ascending aorta, which already 
promotes confidence in the models’ explanatory power and outputs. The prediction of the maximal velocity 
across the aortic valve may play a role in individual prediction of prosthesis-patient mismatch, which has been 
described to be present in 19–70% of cases and was shown to impact mortality and morbidity after aortic valve 
replacement33. Maximal velocity can be converted to maximal gradient across the aortic valve and a difference 
of below 1.5 m/s would be a difference of mean gradient of approximately 4–5 mmHg, which was not consid-
ered to be a clinically relevant difference. The Bland-Altman plot shows only 1 patient with a value of >1.96 
standard deviations for maximum velocity and show statistical comparability. Potentially, even lower differences 
could be of clinical relevance. However in clinical practice current imaging modalities used for assessing peak 
velocity (echo, MRI) also carry a similar risk for uncertainty in their measurements34. The clinical importance of 
differences found for surface averaged WSS values and SFD still need to be closer investigated in future clinical 
outcome-oriented studies. Nevertheless, in the literature WSS associated with normal endothelial function is 
defined as range between 1 and 15 Pa35 or even higher, the difference of 7–10 Pa would be considered as clinically 
acceptable. In 90% of the cases the Bland-Altman plot shows difference within this range. In regard to SFD it is 
Figure 5. Comparison between predicted and post-operative haemodynamic outcome. (A) Comparison of 
blood flow profiles (helicity, vorticity, eccentricity, secondary flow degree) between the model-based prediction 
(CFD) and the post-operative flow profiles (4D Flow MRI) after a surgical procedure are compared. (B) Linear 
regression plots of predicted and post-operative secondary flow degree, surface averaged wall shear stress and 
maximal flow velocity across the valve. (C) Bland-Altman plots of predicted and post-operative secondary flow 
degree, surface averaged wall shear stress and maximal flow velocity across the valve, plotted against the mean. 
The continuous horizontal lines illustrate mean −1.96 and +1.96 standard deviations.
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described that elevation of SFD is present in the ascending aorta of patients with bicuspid aortic valves and asso-
ciated with dilation of the ascending aorta29. In our 10 cases SFD varied between 0.2 and 1.2. In bicuspid aortic 
valve disease SFD of 2.5 has been observed23. Thus, differences of 0.2 we considered as clinically acceptable. In our 
patient cohort 80% of cases showed differences below 0.2.
The correctness of the prediction is limited by the accuracy of the boundary conditions. The personalisation 
of all simulations was achieved by adapting the model as closely as possible to individual anatomical and hae-
modynamic data. We used two anatomical parameters (averaged surface distance and Hausdorff distance) to 
verify the correctness of the geometrical boundary conditions. Instead of an idealized flow profile patient-specific 
LVOT-inflow profiles used were based on 4D MRI data assessed before treatment. By combining the patient’s 
Figure 6. Visualization of WSS distributions using CFD simulations based on post-operative imaging data 
(post-operative) and virtually treated preoperative imaging data (predicted).
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pre-treatment imaging data with a database of aortic valve geometries a valid model of the interplay of LVOT 
specific flow and the open valve characteristics is provided, and was shown to correctly simulate the impact on 
post-operative flow in the ascending aorta36. As described previously5, 6 we also observed disturbances in flow 
profiles and slightly elevated post-surgical flow velocities across biological and mechanical heart valves. As it 
was shown before we were able to confirm good agreement of blood flow patterns and velocity fields between 
4D flow and CFD37. The present study contains data of a small patient cohort where the intent was to establish 
a virtual treatment workflow and validate its results in a first cohort of N = 10 patients. Further validation in 
larger cohorts will be required before considering its routine clinical application. Follow-up MRI were performed 
between 5–277 days after surgical treatment, thus, in few patients remodelling of the left ventricle could already 
have taken place and could have influenced the post-operative outcome parameters, which would not be predict-
able. However, good comparability of the predicted and post-operative parameters suggests that possible effects 
generated by remodelling processes might have only played a minor role. The predictive modelling in general 
is unable to take into account all possible changes in boundary conditions due to the real treatment procedure 
which can be considered a general limitation of all predictive models.
In a growing population of digitally represented patients the conduct of entirely virtual studies can be another 
prospect. Without any risk for the patient, inhomogeneity between treatment groups or carry-over bias, major chal-
lenges of interventional studies as well as conventional single case design trials could be overcome. In a virtual 
intervention cohort patients can safely undergo numerous different treatment methods under identical conditions.
Although cardiovascular models based on imaging data were demonstrated to produce results comparable 
to clinical diagnostic methods22, 37, 38, their combination with interventional study designs remained challenging 
and complex in heart valve disease. A technically and clinically oriented approach has recently helped to identify 
anatomical and functional target parameters in degenerative mitral valve disease with potential use for treatment 
planning39, and Kassab et al. recently highlighted the capabilities of new modelling technologies and quantitative 
approaches to surgical decision making7. It will, however, highly depend on the skills of the surgeon or interven-
tional cardiologist to transfer such decisions to the patient. Additionally, haemodynamic outcome covers only 
one aspect of a treatment procedure. Several other non-haemodynamic problems can arise in patients undergo-
ing AVR, affecting the overall morbidity and mortality40. Despite other risks nearly 50% of AVR procedures are 
linked to coronary artery bypass surgery19, representing an influence on the treatment group that has not yet been 
incorporated into the modelling simulations.
Future research should address these limitations in upcoming clinical trials. As aortic flow patterns were 
demonstrated to be consistent with post-operative patient data future in-silico studies will already be able to 
iteratively explore a variety of treatment options. The overall concept of a CFD-based virtual treatment and the 
validation methodology are not exclusively limited to AVD and could be of value in other structural heart valve 
disease, and in complex cases of congenital heart disease.
Computational modelling is desirable to bridge the gap between the existing situation and the emerging para-
digms of precision medicine, in which patient-specific quantitative metrics and data guide therapy7. Such individ-
ually targeted interventions are likely to have an impact on clinical practice and the decision-making process. Our 
findings already support the potential benefit of clinical application of model-based predictions in aortic valve 
disease in near future. They open up the unprecedented opportunities for improvements in patient care, device 
selection, surgical strategy, and consequently the reduction of risk.
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